HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Laura Borsi Selected Research
Laura Borsi Research Topics
Disease
18
Neoplasms (Cancer)
08/2013 - 03/2002
6
Carcinoma (Carcinomatosis)
04/2010 - 07/2004
3
Necrosis
08/2013 - 07/2010
3
Squamous Cell Carcinoma of Head and Neck
01/2007 - 08/2005
3
Adenocarcinoma
01/2005 - 01/2003
2
Fibrosarcoma
08/2013 - 04/2006
1
Osteosarcoma (Osteogenic Sarcoma)
08/2013
1
Arthritis (Polyarthritis)
11/2011
1
Neoplasm Metastasis (Metastasis)
09/2011
1
Esophageal Neoplasms (Esophageal Cancer)
02/2011
1
Neuroblastoma
07/2010
1
Renal Cell Carcinoma (Grawitz Tumor)
04/2010
1
Cystitis
10/2009
1
Fibrosis (Cirrhosis)
07/2008
1
Myocarditis (Carditis)
07/2008
1
Hematologic Neoplasms (Hematological Malignancy)
06/2008
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2005
1
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/2004
1
Prostatic Intraepithelial Neoplasia
07/2004
1
Colorectal Neoplasms (Colorectal Cancer)
01/2003
1
Teratocarcinoma
12/2002
1
Astrocytoma (Pilocytic Astrocytoma)
11/2002
1
Vascular Tissue Neoplasms
03/2002
Drug/Important Bio-Agent (IBA)
11
Fibronectins (Fibronectin)
IBA
08/2013 - 03/2002
11
Proteins (Proteins, Gene)
FDA Link
08/2013 - 03/2002
7
Tenascin
IBA
10/2009 - 01/2003
6
Immunoglobulin Fragments
IBA
08/2013 - 12/2002
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
07/2010 - 06/2003
4
Protein Isoforms (Isoforms)
IBA
02/2011 - 03/2002
3
Melphalan (Alkeran)
FDA Link
Generic
08/2013 - 04/2006
3
Antibodies
IBA
04/2010 - 11/2002
3
Monoclonal Antibodies
IBA
06/2008 - 12/2002
3
Kalinin
IBA
01/2007 - 08/2005
3
Cytokines
IBA
01/2005 - 03/2002
2
Collagen
IBA
11/2011 - 01/2003
2
Extracellular Matrix Proteins
IBA
09/2011 - 01/2003
2
ErbB Receptors (EGF Receptor)
IBA
02/2011 - 08/2005
2
Therapeutic Uses
IBA
07/2010 - 06/2003
2
Interleukin-2 (IL2)
IBA
07/2010 - 03/2002
2
Messenger RNA (mRNA)
IBA
08/2006 - 07/2004
1
Gemcitabine
FDA Link
08/2013
1
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
09/2011
1
Periostin
IBA
09/2011
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2011
1
vandetanib (ZD6474)
IBA
02/2011
1
Angiogenesis Inhibitors
IBA
02/2011
1
Immunoconjugates (Immunoconjugate)
IBA
02/2011
1
Tyrosine Kinase Inhibitors
IBA
02/2011
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
02/2011
1
RNA Precursors (Precursor, mRNA)
IBA
02/2010
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
07/2008
1
Hydroxyproline (4 Hydroxyproline)
IBA
07/2008
1
platelet-derived growth factor A
IBA
07/2008
1
Phosphotransferases (Kinase)
IBA
07/2008
1
Platelet-Derived Growth Factor
IBA
07/2008
1
Imatinib Mesylate (Gleevec)
FDA Link
07/2008
1
Antigens
IBA
06/2008
1
F8 monoclonal antibody
IBA
06/2008
1
Amino Acids
FDA Link
06/2008
1
p38 Mitogen-Activated Protein Kinases
IBA
08/2005
1
Interleukin-6 (Interleukin 6)
IBA
01/2005
1
Collagen Type V (Type V Collagen)
IBA
01/2005
1
RNA (Ribonucleic Acid)
IBA
07/2004
1
Phenobarbital (Luminal)
FDA Link
07/2004
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
07/2004
1
Interleukin-12 (IL 12)
IBA
06/2003
1
Ligands
IBA
12/2002
1
Calmodulin (Calcium-Dependent Activator Protein)
IBA
12/2002
1
Immunoglobulin G (IgG)
IBA
11/2002
1
Factor VIII (Coagulation Factor VIII)
IBA
11/2002
1
Staphylococcal Protein A (Protein A)
IBA
03/2002
1
Interferon-gamma (Interferon, gamma)
IBA
03/2002
Therapy/Procedure
8
Therapeutics
08/2013 - 12/2002
2
Lasers (Laser)
01/2007 - 07/2006
1
Intravenous Injections
06/2008
1
Aftercare (After-Treatment)
12/2007